Thank you, Presiding Officer. It gives me great pleasure to close tonight’s debate. I congratulate Clare Adamson on securing it and thank her for articulating very emotively her reasons for doing what she can to raise awareness of this incredibly cruel condition and, as the campaign states, to “Demand Better.”
I pay special tribute to John Scott, who was very brave to pay tribute to his late wife in his speech. That was not easy to do, and I sometimes think that these debates, which are often missed by the press, are where we hear members speak the most powerfully and movingly. I pay tribute to John again for contributing to the debate. It is difficult to follow him—I think that everyone has been touched by how he made his case. I wish him well for his own test, which is about to come up.
I welcome to the chamber all those from Pancreatic Cancer UK and all those who have the condition or have a loved one who has been impacted. Their presence is incredibly important and so, too, are their stories, their awareness raising and all the work that they do and effort that they put in to make sure that people know about the condition. I also pay tribute to Nicola Mcmanus’s mum and William Begley. We must ensure that their experience goes on to generate the improvements that we need to see happen across the country.
The Scottish Government recognises the damaging impact of all cancers, including pancreatic cancer, on individuals, their families and their friends. However, we should recognise that there has been some progress over the past 10 years. The overall age-adjusted cancer mortality rate in Scotland has reduced by 11 per cent. That significant improvement is thanks to the efforts of people across the NHS and the third sector. I pay tribute to and sincerely thank all those people who work tirelessly across the country delivering our health and social care services and those who raise awareness of such terrible diseases as pancreatic cancer.
However, we absolutely recognise that there are a small number of cancers, including pancreatic cancer, for which survival rates remain stubbornly low—in part, as members have said, because of late detection. Despite all our efforts and the improvements that we have seen, the UK and Scotland are still behind some other countries in terms of cancer survival rates for a number of tumour types, including—particularly significantly for tonight’s debate—pancreatic cancer, on which we still need to bring about much-needed improvement.
In March 2016, the Scottish Government unveiled its “Beating Cancer: Ambition and Action” strategy, which serves as a blueprint for the future of cancer services in Scotland. The Scottish Government is acutely aware that early detection of all cancers, including pancreatic cancer, is crucial. The earlier that cancer can be diagnosed, the better the chance of a positive outcome.
The cancer strategy will deliver £100 million of investment over the coming years to improve prevention, detection, diagnosis, treatment and aftercare for all those who are affected by cancer. Supporting those ambitions is our £41 million detect cancer early programme, which, over the past five years, has increased diagnostic capacity across Scotland, as well as worked to increase awareness of the signs and symptoms of cancer.
Next year, the programme will focus on the overall benefits of early detection for all cancers. It aims to encourage anyone with any concerns or changes to their body to visit their GP. I will instruct my officials to meet with colleagues from the pancreatic cancer charities to discuss how we can support awareness messages through our wee c strategy and social media and digital channels, and any other channels that are appropriate. We will, of course, extend that invitation to Miss Adamson, if she would like to be part of the meeting.
Another area of work that the Scottish Government has supported in order to improve diagnosis is the Scottish referral guidelines for suspected cancer, which were updated in 2014. Those include a specific section on pancreatic cancer and are intended to help GPs, the wider primary care team, other clinicians, patients and carers to identify those who are most likely to have cancer and who, therefore, require urgent assessment by a specialist. The guidelines include all the tell-tale signs that Clare Adamson, Maree Todd and others outlined, with a clear instruction to have a low threshold for considering further investigation or referral, because of the detection difficulties that we know exist for this cancer.
Once referral is made, we need to ensure that no one has to wait longer than they should to receive a diagnosis and then, if needed, treatment of their cancer. That is why the Cabinet Secretary for Health and Sport has announced the formation of a new ministerial cancer performance delivery group, which will focus on driving forward improvements in waiting times for diagnosis and treatment for cancer patients in Scotland and is backed by an additional £1 million investment to help to address capacity shortfalls in some areas. That is in addition to the £4.85 million of investment made in 2017 to support improvement in diagnostic scopes and imaging capacity for suspected cancer patients.
It is also important that we aim to prevent cancers from occurring in the first place, a point that was made by Colin Smyth. We know that smoking and obesity can be contributory factors in the development of pancreatic cancer. As we all know, Scotland has done much over past years to reduce the harms that come from preventable public health issues, and we have taken forward strategic approaches to tackle drinking, smoking and—this will have an indirect impact on the debate—diet and obesity, a new consultation on which we launched publicly last week.
Most members will be aware of the difficulty of diagnosing pancreatic cancer early. The symptoms are often non-specific and that can mean that people present very late to their GP. It is important that we have a good understanding of that type of tumour to enable NHS Scotland colleagues to treat it more effectively. The Scottish Government has made available via the chief scientist office more than £700,000 to support precision panc, along with the £10 million from Cancer Research UK. That investment will help to improve our understanding of this tumour type and, I hope, lead to more effective treatments. I welcome the increased focus from Cancer Research UK on less survivable cancers, such as pancreatic cancer, and I hope that the increased research capacity helps to improve outcomes for all those affected by this cancer.
Researchers can apply to the Scottish Government CSO for funding, and applications to investigate the diagnosis and treatment of pancreatic cancer would be very welcome. In direct response to Miles Briggs’s point about the fast-track referral and treatment trials that are happening in England, I point out that it will be at least two years before the outcomes of those pilots are known—that is important to know. However, there are processes in place via NHS National Services Scotland and our national cancer clinical services group to ensure that any new emerging evidence from those studies is considered when developing services in Scotland.
We absolutely know that we need to raise awareness of pancreatic cancer. We also know that we need to continue with research and that we need to be mindful of the correlation between cancer prevalence and the inequalities that too many of our communities face.
If we are to make improvements, we also need to be mindful of the stories of those who feel the pain of pancreatic cancer, whether themselves or because their loved ones have had the diagnosis. We demand better for them. As Lynda Murray has said, we will keep on advocating, to ensure that people get a fairer chance of survival.
I pay tribute to Clare Adamson for bringing this important debate to the chamber, and I pay tribute to John Scott and other members who spoke powerfully about the impact of this cruel disease on people they know, whether constituents or loved ones.
I hope that we can work together on research and capacity building to ensure that we bring about the improvements that we need, which have been a long time coming.